YAP activation is an early event and a potential therapeutic target in liver cancer development. [electronic resource]
Producer: 20150626Description: 1088-96 p. digitalISSN:- 1600-0641
- Adaptor Proteins, Signal Transducing -- metabolism
- Adenoma, Liver Cell -- drug therapy
- Adult
- Aged
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis Regulatory Proteins -- antagonists & inhibitors
- Carcinoma, Hepatocellular -- drug therapy
- Cell Cycle Proteins
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Female
- Gene Expression
- Hippo Signaling Pathway
- Humans
- Liver Neoplasms -- drug therapy
- Liver Neoplasms, Experimental -- drug therapy
- Male
- Mice
- MicroRNAs -- genetics
- Middle Aged
- Phosphoproteins -- metabolism
- Porphyrins -- pharmacology
- Precancerous Conditions -- drug therapy
- Protein Serine-Threonine Kinases -- metabolism
- Rats
- Rats, Inbred F344
- Signal Transduction
- Transcription Factors
- Verteporfin
- YAP-Signaling Proteins
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.